BeStock  
Stocks › GLUE

Monte Rosa Therapeutics GLUE

US equityMarket cap rank #3349
$8.64 −$0.27 (-3.03%)
Market closed · Nov 20, 8:20 pm ET · Last extended-hours $8.64 0.00%
Open$8.73
Prev close$8.91
Day range$8.48 – $9.04
Volume2.52M
Market cap$738.29M
P/E (TTM)–
Dividend yield–

Fundamentals

Latest reported quarter: Q3, ended Sep 2026

Revenue$54.37M+325.8% YoY
Operating profit-$1.94M+94.1% YoY
Net profit$3.06M+111.3% YoY
Diluted EPS$0.03+109.1% YoY
Free cash flow-$42.54M-142.6% YoY
Operating cash flow-$40.98M

Revenue, last 8 quarters

$60.6MDec '24$84.9MMar '25$23.2MJun '25$12.8MSep '25$2.8MDec '25$4.2MMar '26$9.0MJun '26$54.4MSep '26

Net profit, last 8 quarters

$13.4MDec '24$46.9MMar '25$-12.3MJun '25$-27.1MSep '25$-46.1MDec '25$-44.5MMar '26$-43.4MJun '26$3.1MSep '26

Diluted EPS by quarter

0.22Dec '240.57Mar '25-0.15Jun '25-0.33Sep '25-0.70Dec '25-0.45Mar '26-0.43Jun '260.03Sep '26

Free cash flow by quarter

$128.7MDec '24$-47.1MMar '25$-36.4MJun '25$99.8MSep '25$-43.8MDec '25$-39.2MMar '26$-48.8MJun '26$-42.5MSep '26

Annual revenue

$0.0FY20$0.0FY21$0.0FY22$0.0FY23$75.6MFY24$123.7MFY25

Profitability & balance sheet

Operating margin-214.5%
Net margin-186.2%
Return on equity-35.3%
Return on assets-22.6%
Return on invested capital-35.1%
Current ratio10.32
Liabilities / assets28.9%
Cash & investments$577.73M
Total debt$32.08M
Net cash (debt)$545.65M

Income statement

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Revenue as Reported $54.37M $8.97M $4.21M $123.67M $2.78M
Total Operating Revenue $54.37M $8.97M $4.21M $123.67M $2.78M
Operating Expense $56.31M $58.10M $54.24M $177.88M $52.50M
Selling and Admin Expenses $10.94M $10.13M $10.18M $36.38M $10.52M
-General & Admin Expense $10.94M $10.13M $10.18M $36.38M $10.52M
Research & Development $45.36M $47.96M $44.07M $141.50M $41.98M
Operating Profit -$1.94M -$49.13M -$50.03M -$54.21M -$49.72M
Net Non-Operating Interest Income (Expense) $5.63M $5.92M $5.59M $12.94M $3.69M
Non-Operating Interest Income $5.63M $5.92M $5.59M $12.94M $3.69M
Other Income (Expense) $93,000.00 $25,000.00 -$8,000.00 $1.54M -$50,000.00
Gain on Sale of Security $93,000.00 $25,000.00 -$8,000.00 $1.48M -$50,000.00
Special Income (Charges) $0.00 $0.00 $0.00 $59,000.00 $0.00
-Gain on Sale of Property/Plant/Equipment $0.00 $0.00 $0.00 $59,000.00 $0.00
Pretax Profit $3.78M -$43.19M -$44.45M -$39.72M -$46.08M
Tax $716,000.00 $208,000.00 $52,000.00 -$1.10M $59,000.00
Net Profit $3.06M -$43.40M -$44.50M -$38.63M -$46.14M
Profit from Continuing Operations $3.06M -$43.40M -$44.50M -$38.63M -$46.14M
Net Income to Parent Company $3.06M -$43.40M -$44.50M -$38.63M -$46.14M
Net Income to Common Stockholders $3.06M -$43.40M -$44.50M -$38.63M -$46.14M
Basic EPS $0.03 -$0.43 -$0.45 -$0.46 -$0.70
Diluted EPS $0.03 -$0.43 -$0.45 -$0.46 -$0.70

Balance sheet

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Assets $697.73M $691.16M $736.43M $448.66M $448.66M
Total Current Assets $640.07M $631.41M $677.55M $393.19M $393.19M
Cash and Cash Equivalents & Short-Term Investments $577.73M $621.10M $666.22M $377.10M $377.10M
-Cash and Cash Equivalents $45.18M $90.10M $159.86M $129.88M $129.88M
-Short Term Investments $532.55M $531.00M $506.36M $247.22M $247.22M
Receivables $57.62M $4.92M $4.61M $11.60M $11.60M
-Other Receivables $57.62M $4.92M $4.61M $11.60M $11.60M
Other Current Assets $4.72M $5.38M $6.72M $4.48M $4.48M
Total Non-Current Assets $57.66M $59.76M $58.88M $55.47M $55.47M
Net PPE $51.98M $53.99M $53.10M $50.37M $50.37M
-Gross PPE $85.67M $85.54M $82.75M $77.99M $77.99M
-Accumulated Depreciation -$33.69M -$31.55M -$29.64M -$27.61M -$27.61M
Other Non-Current Assets $5.69M $5.77M $5.78M $5.10M $5.10M
Total Liabilities $201.52M $203.88M $214.51M $215.60M $215.60M
Total Current Liabilities $62.05M $59.66M $71.04M $64.21M $64.21M
Payables $6.37M $7.15M $7.90M $3.55M $3.55M
-Accounts Payable $3.35M $7.15M $7.90M $3.55M $3.55M
-Total Tax Payable $3.02M – – – –
Current Accrued Expenses $19.12M $18.30M $19.31M $15.12M $15.12M
Short-Term Debt and Capital Lease Obligation $4.19M $4.63M $4.48M $4.40M $4.40M
-Current Capital Lease Obligation $4.19M $4.63M $4.48M $4.40M $4.40M
Current Deferred Liabilities $21.10M $22.10M $33.06M $29.57M $29.57M
Other Current Liabilities $1.94M $1.17M $1.24M $1.58M $1.58M
Total Non-Current Liabilities $139.47M $144.22M $143.48M $151.39M $151.39M
Long Term Debt and Capital Lease Obligation $32.08M $33.36M $34.58M $34.79M $34.79M
-Long Term Capital Lease Obligation $32.08M $33.36M $34.58M $34.79M $34.79M
Non-Current Deferred Liabilities $102.26M $105.62M $103.64M $111.33M $111.33M
Employee Benefits $5.13M $5.24M $5.26M $5.27M $5.27M
Total Equity $496.21M $487.28M $521.92M $233.06M $233.06M
Stockholders' Equity $496.21M $487.28M $521.92M $233.06M $233.06M
Capital Stock $9,000.00 $9,000.00 $8,000.00 $7,000.00 $7,000.00
-Common Stock $9,000.00 $9,000.00 $8,000.00 $7,000.00 $7,000.00
-Preferred Stock $0.00 $0.00 $0.00 – –
Additional Paid-In Capital $1.06B $1.06B $1.05B $714.09M $714.09M
Retained Earnings -$562.05M -$565.11M -$521.72M -$477.21M -$477.21M
Gains/Losses Not Affecting Retained Earnings -$6.19M -$5.17M -$4.75M -$3.83M -$3.83M
Convertible preferred securities – – $0.00 $0.00 $0.00

Cash flow

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Operating Cash Flow -$40.98M -$44.11M -$37.37M -$22.80M -$43.01M
Net cash flow from continuing operations -$40.98M -$44.11M -$37.37M -$22.80M -$43.01M
Net Income from Continuing Operations $3.06M -$43.40M -$44.50M -$38.63M -$46.14M
Depreciation & Depletion & Amortization $2.14M $1.91M $2.03M $8.36M $2.09M
Change in Working Capital -$52.86M -$7.63M $141,000.00 -$9.19M -$3.36M
-Change in Receivables -$52.70M -$311,000.00 $6.99M -$11.43M -$6.64M
-Change in Prepaid Assets $728,000.00 $1.34M -$2.92M $604,000.00 $1.38M
-Change in Payables and Accrued Expense $4.55M $717,000.00 $665,000.00 -$5.86M -$1.88M
-Change In Other Working Capital -$5.43M -$9.37M -$4.59M $7.49M $3.77M
Net cash flow from investing -$4.54M -$28.86M -$261.00M -$101.83M -$65.07M
Net Cash Flow from Continuing Investing Activities -$4.54M -$28.86M -$261.00M -$101.83M -$65.07M
Net PPE Purchase and Sale -$1.56M -$4.72M -$1.87M -$4.70M -$767,000.00
Net Investment Purchase and Sale -$2.98M -$24.14M -$259.13M -$97.13M -$64.30M
Financing Cash Flow $568,000.00 $3.21M $328.34M $30.35M $29.62M
Net Cash Flow from Continuing Financing Activities $568,000.00 $3.21M $328.34M $30.35M $29.62M
Net Common Stock Issuance $0.00 $0.00 $324.30M $23.89M $23.89M
Proceeds from Stock Option Exercised $568,000.00 $3.21M $4.52M $6.46M $5.73M
Net Other Financing Charges $0.00 $0.00 -$487,000.00 – –
Ending Cash Balance $50.10M $95.04M $164.81M $134.84M $134.84M
Net Change in Cash -$44.95M -$69.76M $29.97M -$94.28M -$78.46M
Beginning Cash Balance $95.04M $164.81M $134.84M $229.12M $213.29M
Free Cash Flow -$42.54M -$48.84M -$39.24M -$27.50M -$43.78M
Gain/Loss from Continuing Operations – – – -$59,000.00 $0.00

Discussion

No comments yet — be the first to weigh in on GLUE.

Sign in to join the discussion.

Scroll to Top